TD Cowen on Roivant Sciences (ROIV): 'We Like the Risk/Reward Profile of the Stock'

September 2, 2025 9:28 AM EDT Send to a Friend
TD Cowen analyst Yaron Werber reiterated a Buy rating and {REMOVEPT} price target on Roivant Sciences (NASDAQ: ROIV).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login